Capstone Investment Advisors
IRON icon

Capstone Investment Advisors’s Disc Medicine IRON Stock Holding History

Capstone Investment Advisors’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245K Sell
3,355
-2,910
-46% -$200K ﹤0.01% 1541
2026
Q1 		$401K Buy
+6,265
New +$435K ﹤0.01% 1247

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capstone Investment Advisors's IRON Position: Q2 2026 in Review

Capstone Investment Advisors reduced its Disc Medicine (IRON) stake by 46% in Q2 2026, selling an estimated $200K and leaving 3,355 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #1541.

Capstone Investment Advisors first reported a position in IRON in Q1 2026 and has held it in 2 quarters since. The position peaked at $401K in Q1 2026. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Capstone Investment Advisors held 3,355 shares of Disc Medicine worth $245K as of Q2 2026.
  • Capstone Investment Advisors sold 2,910 Disc Medicine shares in Q2 2026, an estimated $200K.
  • Disc Medicine made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1541 holding.
  • Capstone Investment Advisors first reported a position in Disc Medicine in Q1 2026 and has held it in 2 quarters since.
  • Capstone Investment Advisors's Disc Medicine position peaked at $401K in Q1 2026.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.